Haemonetics Corp. (HAE) Tops Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $91.34 --0%
Financial Fact:
Cost of goods sold: 116.01M
Today's EPS Names:
FRMM, PETS, DARE, More
Financial Fact:
Cost of goods sold: 116.01M
Today's EPS Names:
FRMM, PETS, DARE, More
Join SI Premium – FREE
Haemonetics Corp. (NYSE: HAE) reported Q2 EPS of $0.47, $0.01 better than the analyst estimate of $0.46. Revenue for the quarter came in at $227.6 million versus the consensus estimate of $229.9 million.
For earnings history and earnings-related data on Haemonetics Corp. (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
- Spruce Biosciences (SPRB) PT Lowered to $144 at Citizens on Higher OpEx, Net Loss
- Morgan Stanley Upgrades Oil India Ltd. (OINL:IN) to Equalweight
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
